The p27 protein, a cyclin-dependent kinase (CDK) inhibitor and a negative regulator of cell cycle control, is a crucial downstream effector of the EGFR tyrosine kinase inhibitor (TKI)-mediated growth blockage in cancer cells [31,32]. Here, EGFR is linked to cancer.